"10.1371_journal.pone.0119803","plos one","2015-03-25T00:00:00Z","Mohammed Akli Ayoub; Yuan Zhang; Robyn S Kelly; Heng B See; Elizabeth K M Johnstone; Elizabeth A McCall; James H Williams; Darren J Kelly; Kevin D G Pfleger","Molecular Endocrinology and Pharmacology, Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, Western Australia, Australia; Centre for Medical Research, The University of Western Australia, Crawley, Western Australia, Australia; Department of Medicine, St. Vincent's Hospital, The University of Melbourne, Melbourne, Victoria, Australia; Dimerix Bioscience Limited, Nedlands, Western Australia, Australia","Conceived and designed the experiments: MAA YZ EAM JHW DJK KDGP. Performed the experiments: MAA YZ RSK HBS EKMJ. Analyzed the data: MAA YZ RSK HBS EKMJ DJK KDGP. Wrote the paper: MAA YZ EKMJ DJK KDGP.","The authors have read the journal’s policy and have the following conflicts: EAM, JHW and KDGP have minor shareholdings in Dimerix Bioscience Limited, a spin-out company of The University of Western Australia that owns intellectual property relating to data presented in this manuscript. EAM is a consultant, JHW is a Director and KDGP is Chief Scientific Advisor of Dimerix Bioscience. KDGP is a named inventor on issued and pending patents covering the GPCR-HIT technology (WO/2008/055313 Detection System and Uses Therefor). EAM, JHW and KDGP are named inventors on issued and pending patents covering a combination therapy targeting the receptors described in this publication (WO/2012/094703 Combination Therapy). This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials. YZ, RSK, HBS, EKMJ and DJK have no conflicts of interest.","2015","03","Mohammed Akli Ayoub","MAA",9,TRUE,6,5,7,5,TRUE,TRUE,FALSE,0,NA,FALSE
